Latest news
Abbott Completes Enrollment in Trial to Evaluate Coronary IVL System - dicardiology.comdicardiology.com · Fri, 07 Aug 2026 02:32:48 GMTLexicon Pharmaceuticals Reports Q2 2026 Results; Completes Enrollment in Phase 3 SONATA-HCM Study and Advances ZYNQUISTA NDA Resubmission - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:44:00 GMTKodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026 - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 11:00:00 GMTOpus Genetics Completes Phase 3 Enrollment for AAV Gene Therapy OPGx-LCA5 - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 19:39:16 GMTEyePoint Completes Enrollment in Two Phase 3 Trials Evaluating Duravyu for DME - Eyewire+Eyewire+ · Wed, 05 Aug 2026 18:46:05 GMTGlaukos completes enrollment in PRESERFLO MicroShunt pivotal study - Glance by Eyes On EyecareGlance by Eyes On Eyecare · Tue, 04 Aug 2026 19:44:43 GMTOpus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease - Eyewire+Eyewire+ · Tue, 04 Aug 2026 13:06:40 GMTVantage Biosciences Completes Enrollment in Phase 2 SeeClear Study of Oral Oruvestat in Non-Proliferative Diabetic Retinopathy - The Manila TimesThe Manila Times · Tue, 04 Aug 2026 11:16:58 GMT